Приложения: алгоритмы принятия решений на разных этапах оказания медицинской помощи и маршрутизация пациентов


DOI: https://dx.doi.org/10.18565/therapy.2022.1suppl.1-147

139-1.jpg (404 KB)

140-1.jpg (484 KB)

141-1.jpg (371 KB)

142-1.jpg (514 KB)

143-1.jpg (327 KB)

144-1.jpg (477 KB)

145-1.jpg (520 KB)

146-1.jpg (244 KB)


Литература


  1. Connors J.M., Levy J.H. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020; 135(23): 2033–40. https://dx.doi.org/10.1182/blood.2020006000.

  2. Richardson S., Hirsch J.S., Narasimhan M. et al. The Northwell COVID-19 research consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020; 323(20): 2052–59. https://dx.doi.org/10.1001/jama.2020.6775.

  3. Zhang H., Liao Y.-S., Gong J. et al. Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases. Dig Liver Dis. 2020; 52(10): 1076–79. https://dx.doi.org/10.1016/j.dld.2020.04.034.

  4. Lapostolle F., Schneider E., Vianu I. et al. Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: The COVID-call study. Intern Emerg Med. 2020; 15(5): 813–17. https://dx.doi.org/10.1007/s11739-020-02379-z.

  5. Lechien J.R., Chiesa-Estomb C.M., Place S. et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020; 288(3): 335–44. https://dx.doi.org/10.1111/joim.13089.

  6. Argenziano M.G., Bruce S.L., Slater C.L. et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: Retrospective case series. BMJ. 2020; 369: m1996. https://dx.doi.org/10.1136/bmj.m1996.

  7. Guan W.J., Liang W.H., Zhao Y. et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. Eur Respir J. 2020; 55(5):2000547. https://dx.doi.org/10.1183/13993003.00547-2020.

  8. Zhang J., Wang X., Jia X. et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020; 26(6): 767–72. https://dx.doi.org/10.1016/j.cmi.2020.04.012.

  9. Sudre C.H., Lee K.A., Ni Lochlainn M. et al. Symptom clusters in Covid-19: A potential clinical prediction tool from the COVID Symptom Study App. Sci Adv. 2021; 7(12): eabd4177. https://dx.doi.org/10.1126/sciadv.abd4177.

  10. Rubio-Rivas M., Corbella X., Mora-Lujan J.M. et al. Predicting clinical outcome with phenotypic clusters in COVID-19 pneumonia: An analysis of 12,066 hospitalized patients from the Spanish registry SEMI-COVID-19. J Clin Med. 2020; 9(11): 3488. https://dx.doi.org/10.3390/jcm9113488.

  11. NICE. COVID-19 rapid guideline: Managing the long-term effects of COVID-19. URL: https://www.nice.org.uk/guidance/ng188 (date of access – 11.01.2021).

  12. Rimmer A. Covid-19: Impact of long term symptoms will be profound, warns BMA. BMJ. 2020; 370: m3218. https://dx.doi.org/10.1136/bmj.m3218.

  13. Greenhalgh T., Knight M., A’Court C. et al. Management of post-acute covid-19 in primary care. BMJ. 2020; 370: m3026. https://dx.doi.org/10.1136/bmj.m3026.

  14. Ramos-Casals M., Brito-Zeon P., Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol. 2021; 17(6): 315–32. https://dx.doi.org/10.1038/s41584-021-00608-z.

  15. Tenforde M.W., Kim S.S., Lindsell C.J. et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network – United States, March–June 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(30): 993–98. https://dx.doi.org/10.15585/mmwr.mm6930e1.

  16. Daher A., Balfanz P., Cornelissen C. et al. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae. Respir Med. 2020; 174: 106197. https://dx.doi.org/10.1016/j.rmed.2020.106197.

  17. Rosales-Castillo A., Rios C.G.D.L., Garca J.D.M. Persistent symptoms after acute COVID-19 infection: Importance of follow-up. Med Clin (Barc). 2021; 156(1): 35–36. https://dx.doi.org/10.1016/j.medcli.2020.08.001.

  18. Carfi A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020; 324(6): 603–5. https://dx.doi.org/10.1001/jama.2020.12603.

  19. Mandal S., Barnett J., E Brill S. et al.; ARC Study Group. «Long-COVID»: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021; 76(4): 396–98. https://dx.doi.org/10.1136/thoraxjnl-2020-215818.

  20. Zhao Y.-M., Shang Y.-M., Song W.-B. et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020; 25: 100463. https://dx.doi.org/ 10.1016/j.eclinm.2020.100463.

  21. Garrigues E., Janvier P., Kherabi Y. et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020; 81(6): e4–e6. https://dx.doi.org/10.1016/j.jinf.2020.08.029.

  22. Townsend L., Dyer A.H., Jones K. et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020; 15(11): e0240784. https://dx.doi.org/10.1371/journal.pone.0240784.

  23. Milanese M., Corsic A.G., Bellofiore S. et al. Suggestions for lung function testing in the context of COVID-19. Respir Med. 2020; 177: 106292. https://dx.doi.org/10.1016/j.rmed.2020.106292. Online ahead of print.

  24. Carvalho-Schneider C., Laurent E., Lemaignen A. et al. Follow-up of adults with non-critical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021; 27(2): 258–63. https://dx.doi.org/10.1016/j.cmi.2020.09.052.

  25. Lambert N.J. & Survivor Corps. COVID-19 «Long Hauler» symptoms survey report. Indiana University School of Medicine; 2020. URL: https://dig.abclocal.go.com/wls/documents/2020/072720-wls-covid-symptom-study-doc.pdf (date of access – 11.01.2021).

  26. Cho R.H.W., To Z.W.H., Yeung Z.W. et al. COVID-19 viral load in the severity of and recovery from olfactory and gustatory dysfunction. Laryngoscope. 2020; 130(11): 2680–85. https://dx.doi.org/10.1002/lary.29056.

  27. Caronna E., Ballve A., Llaurado A. et al. Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020; 40(13): 1410–21. https://dx.doi.org/10.1177/0333102420965157.

К содержанию номера

Бионика Медиа